INGEVITY CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.8 USD | +5.61% |
|
+14.48% | +16.05% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,655 | 3,126 | 2,817 | 2,632 | 1,711 | 1,883 | - | - |
| Enterprise Value (EV) 1 | 4,827 | 4,136 | 3,791 | 4,028 | 3,082 | 3,141 | 2,902 | 2,784 |
| P/E ratio | 20.1 x | 16.9 x | 24.3 x | 12.8 x | -315 x | 14.1 x | 10.5 x | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 2.83 x | 2.57 x | 2.02 x | 1.58 x | 1.01 x | 1.29 x | 1.21 x | 1.18 x |
| EV / Revenue | 3.73 x | 3.4 x | 2.72 x | 2.41 x | 1.82 x | 2.14 x | 1.87 x | 1.75 x |
| EV / EBITDA | 12.2 x | 10.4 x | 8.98 x | 8.9 x | 7.77 x | 8.26 x | 6.5 x | 5.93 x |
| EV / FCF | 30 x | 15.3 x | 20 x | 23.6 x | 32.3 x | 33.8 x | 15.7 x | 14.3 x |
| FCF Yield | 3.33% | 6.54% | 4.99% | 4.24% | 3.09% | 2.96% | 6.38% | 6.97% |
| Price to Book | 6.89 x | 4.9 x | 4.18 x | 3.76 x | - | - | - | - |
| Nbr of stocks (in thousands) | 41,824 | 41,279 | 39,286 | 37,372 | 36,231 | 36,281 | - | - |
| Reference price 2 | 87.38 | 75.73 | 71.70 | 70.44 | 47.22 | 51.89 | 51.89 | 51.89 |
| Announcement Date | 03/02/20 | 10/02/21 | 23/02/22 | 27/02/23 | 21/02/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,293 | 1,216 | 1,392 | 1,668 | 1,692 | 1,465 | 1,553 | 1,590 |
| EBITDA 1 | 396.9 | 397.9 | 422.2 | 452.6 | 396.8 | 380.2 | 446.3 | 469.5 |
| EBIT 1 | 311.9 | 297.7 | 312.3 | 343.8 | 76.9 | 238 | 329.2 | 346 |
| Operating Margin | 24.12% | 24.48% | 22.44% | 20.61% | 4.54% | 16.25% | 21.2% | 21.75% |
| Earnings before Tax (EBT) 1 | 227.9 | 235.1 | 162.8 | 269.6 | -10.1 | 172.4 | 239 | - |
| Net income 1 | 183.7 | 186.2 | 118.1 | 211.6 | -5.4 | 133.4 | 184.9 | - |
| Net margin | 14.21% | 15.31% | 8.49% | 12.68% | -0.32% | 9.11% | 11.9% | - |
| EPS 2 | 4.350 | 4.480 | 2.950 | 5.500 | -0.1500 | 3.675 | 4.957 | - |
| Free Cash Flow 1 | 160.9 | 270.3 | 189.2 | 170.6 | 95.3 | 93 | 185.2 | 194 |
| FCF margin | 12.44% | 22.23% | 13.6% | 10.23% | 5.63% | 6.35% | 11.92% | 12.2% |
| FCF Conversion (EBITDA) | 40.54% | 67.93% | 44.81% | 37.69% | 24.02% | 24.46% | 41.49% | 41.32% |
| FCF Conversion (Net income) | 87.59% | 145.17% | 160.2% | 80.62% | - | 69.72% | 100.16% | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 03/02/20 | 10/02/21 | 23/02/22 | 27/02/23 | 21/02/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 376.8 | 336 | 382.8 | 419.9 | 482 | 383.6 | 392.6 | 481.8 | 446 | 371.7 | 340.1 | 423.4 | 401 | 322.8 | 332.9 |
| EBITDA 1 | 119.5 | 79.6 | 119 | 121.1 | 138.2 | 74.3 | 103.9 | 120.7 | 110.4 | 61.8 | 76.9 | 106.6 | 114.2 | 90.82 | 89.83 |
| EBIT 1 | 91.9 | 51.4 | 88.3 | 91.6 | 107.3 | 44.1 | 72.8 | 69.3 | 55.2 | -131.3 | 47.3 | 75.13 | 85.37 | 58 | 79.1 |
| Operating Margin | 24.39% | 15.3% | 23.07% | 21.81% | 22.26% | 11.5% | 18.54% | 14.38% | 12.38% | -35.32% | 13.91% | 17.75% | 21.29% | 17.97% | 23.76% |
| Earnings before Tax (EBT) 1 | -9 | 36.3 | 77.6 | 76.5 | 95.8 | 19.7 | 64.1 | 47.7 | 32.1 | -154 | -71.9 | 49.9 | 60.5 | 33.75 | 39.4 |
| Net income 1 | -4.2 | 29.3 | 60.8 | 59.8 | 75.4 | 15.6 | 50.7 | 35.5 | 25.2 | -116.8 | -56 | 19.95 | 46.55 | 26 | 30.35 |
| Net margin | -1.11% | 8.72% | 15.88% | 14.24% | 15.64% | 4.07% | 12.91% | 7.37% | 5.65% | -31.42% | -16.47% | 4.71% | 11.61% | 8.06% | 9.12% |
| EPS 2 | -0.1100 | 0.7400 | 1.550 | 1.540 | 1.980 | 0.4100 | 1.350 | 0.9700 | 0.6900 | -3.230 | -1.540 | 1.030 | 1.223 | 0.8300 | 0.8350 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 27/10/21 | 23/02/22 | 04/05/22 | 02/08/22 | 02/11/22 | 27/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 21/02/24 | 01/05/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 1,172 | 1,010 | 975 | 1,396 | 1,371 | 1,258 | 1,019 | 901 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.953 x | 2.538 x | 2.308 x | 3.084 x | 3.456 x | 3.309 x | 2.283 x | 1.919 x |
| Free Cash Flow 1 | 161 | 270 | 189 | 171 | 95.3 | 93 | 185 | 194 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | 12.70 | 15.50 | 17.20 | 18.70 | - | - | - | - |
| Cash Flow per Share | 6.530 | 8.480 | 7.310 | - | - | - | - | - |
| Capex 1 | 115 | 82.1 | 104 | 143 | 110 | 117 | 115 | 117 |
| Capex / Sales | 8.88% | 6.75% | 7.46% | 8.54% | 6.49% | 7.96% | 7.43% | 7.36% |
| Announcement Date | 03/02/20 | 10/02/21 | 23/02/22 | 27/02/23 | 21/02/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
51.89
USD
Average target price
59
USD
Spread / Average Target
+13.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.05% | 1.88B | |
| +1.22% | 76.93B | |
| -0.28% | 46.86B | |
| +1.07% | 32.74B | |
| +10.05% | 18.58B | |
| -9.81% | 11.54B | |
| +6.79% | 11.14B | |
| -6.33% | 9.8B | |
| +5.97% | 9.72B | |
| +7.57% | 9.3B |
- Stock Market
- Equities
- NGVT Stock
- Financials Ingevity Corporation
